Meniere's Disease: A Comprehensive Overview
Definition and Core Clinical Features
Meniere's disease is a chronic inner ear disorder characterized by recurrent spontaneous vertigo attacks lasting 20 minutes to 12 hours, accompanied by fluctuating low- to mid-frequency sensorineural hearing loss, tinnitus, and aural fullness in the affected ear 1.
The disease typically presents in adults between 40-70 years of age and represents a failure of inner ear homeostasis rather than a simple pressure phenomenon 1, 2.
Pathophysiology
Underlying Mechanism
The hallmark pathological finding is endolymphatic hydrops (EH)—excessive accumulation of endolymph fluid in the membranous labyrinth 1, 3. However, recent evidence suggests this is more complex than previously understood:
- EH reflects proliferative epithelial growth rather than simple pressure-induced distension 4
- The condition represents endolymphatic sac (ELS) failure leading to impaired inner ear homeostasis 4, 2
- Two major disease endotypes exist: hypoplastic and degenerative, defined by distinct endolymphatic sac pathologies 4
Important caveat: While EH is the characteristic histopathological finding, it may represent a secondary manifestation rather than the primary driver of symptoms 5. The exact etiology remains multifactorial, involving genetic, autoimmune, infectious, traumatic, and allergic factors 6.
Diagnostic Criteria
Definite Meniere's Disease (2015 Criteria)
To diagnose definite MD, all three criteria must be met 1:
- Two or more spontaneous vertigo attacks, each lasting 20 minutes to 12 hours
- Audiometrically documented fluctuating low- to mid-frequency sensorineural hearing loss in the affected ear on at least one occasion before, during, or after a vertigo episode
- Fluctuating aural symptoms (hearing loss, tinnitus, or fullness) in the affected ear
Key Diagnostic Distinctions
Vertigo vs. Imbalance: True vertigo is a sensation of self-motion (rotary spinning) or environmental movement when neither is occurring. This differs from imbalance, which is unsteadiness without spinning and may be ongoing rather than episodic 1.
Drop Attacks (Tumarkin's Otolithic Crisis): Some patients in later stages experience sudden falls during MD attacks without warning or loss of consciousness—these are not present in every patient 1.
Diagnostic Testing Algorithm
When MD is suspected, proceed systematically 1:
Audiometry (mandatory): Documents low- to mid-frequency SNHL; takes ~30 minutes with no significant risk
Vestibular testing (video/electronystagmography): Evaluates vestibular function by recording eye movements with caloric stimulation; takes ~1 hour; risks include vertigo, nausea, and positional discomfort
Electrocochleography: Measures electrical responses of cochlea and auditory nerve; may cause ear discomfort
MRI with contrast (when indicated): Rules out vestibular schwannoma and other central pathology; can now visualize EH directly in vivo 3, 4. Risks include contrast allergy and claustrophobia
Critical pitfall: Physical examination is often unremarkable, and conventional imaging may be normal 1. The diagnosis relies heavily on clinical criteria and audiometric documentation.
Differential Diagnosis Considerations
Vestibular migraine is the most important alternative diagnosis to exclude, as there is significant symptom overlap and high migraine prevalence in MD patients 7, 8. However, current evidence strongly favors MD as a primary inner ear disorder based on:
- Genetic and histologic changes of hydrops
- Imaging showing hydropic changes
- Predominance of low-frequency hearing loss
- Clinical efficacy of treatments targeting inflammatory change/hydrops
- Clinical efficacy of vestibular end-organ ablation 7
Treatment Approach: Stepwise Algorithm
The primary treatment goals are to reduce vertigo frequency and severity, preserve hearing, relieve tinnitus and aural fullness, and improve quality of life 1.
Step 1: Conservative Management (First-Line)
Begin with lifestyle and dietary modifications 1:
- Low-sodium diet: 1,500-2,300 mg daily (based on American Heart Association guidelines, not older MD-specific recommendations)
- Limit alcohol consumption
- Limit caffeine intake
- Identify and manage triggers: sodium, alcohol, caffeine, weather changes, allergies, stress
Rationale: These modifications address potential triggers with minimal risk. Up to 60% of patients show symptom improvement with placebo in RCTs, emphasizing the importance of conservative measures 1.
Step 2: Medical Therapy
When conservative measures are insufficient 1:
- Diuretics: Remove excess body fluid
- Antivertigo medications: For acute vertigo symptoms
- Antihistamines: Treat allergic components
- Betahistine: Histamine analogue increases vasodilation to inner ear (not FDA-approved in US but used internationally)
For acute attacks: Antivertigo medications provide symptomatic relief during episodes.
Step 3: Noninvasive Adjunctive Therapies
- Vestibular rehabilitation: Physical therapy for balance compensation; should await 3 months of stability and be supervised by a rehabilitation professional—self-rehabilitation is not recommended 9
- Hearing aids: For serviceable hearing (Classes A, B, or C on AAO-HNS scale) 1
Hearing classification (AAO-HNS Scale):
- Class A: Discrimination 70-100%; PTA <30 dB
- Class B: Discrimination 50-69%; PTA 31-50 dB
- Class C: Discrimination 50-69%; PTA >50 dB
- Class D: Discrimination <50%; any PTA
Classes A, B, and C are considered usable/serviceable hearing; Class D is not 1.
Step 4: Intratympanic Injections
When medical treatment fails to suppress vertigo attacks 1, 3:
- Intratympanic steroids: Less destructive option
- Intratympanic gentamicin: Chemical ablation of vestibular function; more definitive but risks hearing loss
Decision point: Choose based on hearing status and patient preference regarding hearing preservation.
Step 5: Surgical Intervention
For refractory cases 1:
- Endolymphatic sac decompression: Hearing-sparing procedure
- Vestibular nerve section: Hearing-sparing, more invasive
- Labyrinthectomy: Hearing-ablative; reserved for non-serviceable hearing (Class D)
Surgical algorithm: Prioritize hearing-sparing procedures when usable hearing remains; consider ablative procedures only when hearing is already non-serviceable.
Natural History and Prognosis
MD follows an unpredictable course 1, 5:
- Vertigo attacks and fluctuations in hearing, tinnitus, and aural fullness are sporadic and unpredicted
- Hearing may worsen, persist, or stabilize over time
- Residual or permanent inner ear balance loss may develop
- Some patients develop chronic imbalance or "vague" dizziness, especially elderly patients with long-standing disease 1
Quality of life impact: MD significantly affects daily functioning, causing fatigue, difficulty hearing and concentrating, and anxiety about future attacks 1.
Common Pitfalls to Avoid
Misdiagnosing vestibular migraine as MD: Ensure strict adherence to diagnostic criteria requiring documented audiometric changes 8
Premature surgical intervention: Exhaust conservative and medical options first; up to 60% show placebo response 1
Starting vestibular rehabilitation during active disease: Wait for 3 months of stability 9
Ignoring bilateral involvement: Some patients develop bilateral disease; monitor both ears
Overlooking comorbid conditions: Consider vitamin D deficiency and other modifiable factors 5
Assuming all EH causes symptoms: Some patients have EH without clinical MD; the relationship is complex 3
Emerging Concepts
Recent advances have transformed understanding of MD 4, 2:
- In vivo imaging now enables direct visualization of EH and endolymphatic sac anatomy
- Endotype stratification allows personalized management based on hypoplastic vs. degenerative pathology
- Genetic analyses are becoming feasible with improved phenotyping
- The disease model now resembles renal insufficiency—a failure of homeostatic function rather than simple pressure overload
These developments demand more stringent diagnostic criteria and open doors to targeted genetic and personalized treatments 2.